Monday, June 17, 2024
HomeTagsSOLIRIS

SOLIRIS

Long-term ALPHA Phase III trial data showed danicopan as add-on to ULTOMIRIS® or SOLIRIS® sustained clinical improvements in subset of patients with PNH experiencing...

Positive results from the 24-week and long-term extension (LTE) period of the pivotal ALPHA Phase III trial showed danicopan as add-on to standard of...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics